Healthy Clinical Trial
Official title:
Characterization of the Effects on Bioimpedance and the Sensorimotor System After the Application of Percutaneous Electrolysis Protocols on the Patellar Tendon.
| Verified date | May 2023 |
| Source | Clinica Francisco Ortega Rehabilitacion Avanzada SL |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Percutaneous electrolysis is a physical therapy technique, whose main objective is the treatment of the signs and symptoms associated with tendinopathies by applying a galvanic current through a blunt dry needle. Despite its clinical use being already stablished, the physiological mechanisms underlying this therapy are still unknown and thus, the optimal parameterization. The present study proposes to perform different stimulation protocols of percutaneous electrolysis on healthy subjects patellar tendon to answer those questions.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | May 2, 2023 |
| Est. primary completion date | May 2, 2023 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 45 Years |
| Eligibility | Inclusion Criteria: - Healthy. - Between 18 and 45 years old. Exclusion Criteria: - to suffer or to have suffered any pathology on the arm on the last 30 days. - to suffer some disease discouraging current application or needling, as coagulation deficit, etc. - to suffer some severe disease as diabetes mellitus, cancer, neurology disease, depression, fibromyalgia, etc. - to suffer some cognitive disorders. - to consume drugs as coagulants, anti-depressant, pregabalin, neuropeptide, opioids, etc during investigation or the first week before investigation. - to consume NSAIDS the last 48 hours before investigation or during investigation. - belonephobia. - To consume caffeine 2 hours prior to the investigation or perform intense exercise on the same day as the measurement. - To receive concomitant physical therapy treatments or have previously received percutaneous electrolysis treatment. - professional athlete - To be pregnant. |
| Country | Name | City | State |
|---|---|---|---|
| Spain | Ionclinics & DEIONICS. | Valencia |
| Lead Sponsor | Collaborator |
|---|---|
| Clinica Francisco Ortega Rehabilitacion Avanzada SL | Ionclinics & DEIONICS. |
Spain,
Abat F, Diesel WJ, Gelber PE, Polidori F, Monllau JC, Sanchez-Ibanez JM. Effectiveness of the Intratissue Percutaneous Electrolysis (EPI(R)) technique and isoinertial eccentric exercise in the treatment of patellar tendinopathy at two years follow-up. Mus — View Citation
Abat F, Valles SL, Gelber PE, Polidori F, Jorda A, Garcia-Herreros S, Monllau JC, Sanchez-Ibanez JM. An experimental study of muscular injury repair in a mouse model of notexin-induced lesion with EPI(R) technique. BMC Sports Sci Med Rehabil. 2015 Apr 17; — View Citation
Abat F, Valles SL, Gelber PE, Polidori F, Stitik TP, Garcia-Herreros S, Monllau JC, Sanchez-Ibanez JM. [Molecular repair mechanisms using the Intratissue Percutaneous Electrolysis technique in patellar tendonitis]. Rev Esp Cir Ortop Traumatol. 2014 Jul-Au — View Citation
Aparecida da Silva V, Galhardoni R, Teixeira MJ, Ciampi de Andrade D. Not just a matter of pain intensity: Effects of three different conditioning stimuli on conditioned pain modulation effects. Neurophysiol Clin. 2018 Oct;48(5):287-293. doi: 10.1016/j.ne — View Citation
Arias-Buria JL, Truyols-Dominguez S, Valero-Alcaide R, Salom-Moreno J, Atin-Arratibel MA, Fernandez-de-Las-Penas C. Ultrasound-Guided Percutaneous Electrolysis and Eccentric Exercises for Subacromial Pain Syndrome: A Randomized Clinical Trial. Evid Based — View Citation
Barlas P, Ting SL, Chesterton LS, Jones PW, Sim J. Effects of intensity of electroacupuncture upon experimental pain in healthy human volunteers: a randomized, double-blind, placebo-controlled study. Pain. 2006 May;122(1-2):81-9. doi: 10.1016/j.pain.2006. — View Citation
Cagnie B, Dewitte V, Barbe T, Timmermans F, Delrue N, Meeus M. Physiologic effects of dry needling. Curr Pain Headache Rep. 2013 Aug;17(8):348. doi: 10.1007/s11916-013-0348-5. — View Citation
Cannell LJ, Taunton JE, Clement DB, Smith C, Khan KM. A randomised clinical trial of the efficacy of drop squats or leg extension/leg curl exercises to treat clinically diagnosed jumper's knee in athletes: pilot study. Br J Sports Med. 2001 Feb;35(1):60-4 — View Citation
Cardoso TB, Pizzari T, Kinsella R, Hope D, Cook JL. Current trends in tendinopathy management. Best Pract Res Clin Rheumatol. 2019 Feb;33(1):122-140. doi: 10.1016/j.berh.2019.02.001. Epub 2019 Mar 8. — View Citation
Cook JL, Khan KM, Harcourt PR, Kiss ZS, Fehrmann MW, Griffiths L, Wark JD. Patellar tendon ultrasonography in asymptomatic active athletes reveals hypoechoic regions: a study of 320 tendons. Victorian Institute of Sport Tendon Study Group. Clin J Sport Me — View Citation
Cook JL, Malliaras P, De Luca J, Ptasznik R, Morris M. Vascularity and pain in the patellar tendon of adult jumping athletes: a 5 month longitudinal study. Br J Sports Med. 2005 Jul;39(7):458-61; discussion 458-61. doi: 10.1136/bjsm.2004.014530. — View Citation
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10. — View Citation
de la Cruz Torres B, Albornoz Cabello M, Garcia Bermejo P, Naranjo Orellana J. Autonomic responses to ultrasound-guided percutaneous needle electrolysis of the patellar tendon in healthy male footballers. Acupunct Med. 2016 Aug;34(4):275-9. doi: 10.1136/a — View Citation
Docking SI, Ooi CC, Connell D. Tendinopathy: Is Imaging Telling Us the Entire Story? J Orthop Sports Phys Ther. 2015 Nov;45(11):842-52. doi: 10.2519/jospt.2015.5880. Epub 2015 Sep 21. — View Citation
Eckenrode BJ, Kietrys DM, Stackhouse SK. PAIN SENSITIVITY IN CHRONIC ACHILLES TENDINOPATHY. Int J Sports Phys Ther. 2019 Dec;14(6):945-956. — View Citation
Fernandez-Rodriguez T, Fernandez-Rolle A, Truyols-Dominguez S, Benitez-Martinez JC, Casana-Granell J. Prospective Randomized Trial of Electrolysis for Chronic Plantar Heel Pain. Foot Ankle Int. 2018 Sep;39(9):1039-1046. doi: 10.1177/1071100718773998. Epub — View Citation
Figueroa D, Figueroa F, Calvo R. Patellar Tendinopathy: Diagnosis and Treatment. J Am Acad Orthop Surg. 2016 Dec;24(12):e184-e192. doi: 10.5435/JAAOS-D-15-00703. — View Citation
Fruhstorfer H, Gross W, Selbmann O. von Frey hairs: new materials for a new design. Eur J Pain. 2001;5(3):341-2. doi: 10.1053/eujp.2001.0250. — View Citation
Goldin M, Malanga GA. Tendinopathy: a review of the pathophysiology and evidence for treatment. Phys Sportsmed. 2013 Sep;41(3):36-49. doi: 10.3810/psm.2013.09.2019. — View Citation
Golman M, Wright ML, Wong TT, Lynch TS, Ahmad CS, Thomopoulos S, Popkin CA. Rethinking Patellar Tendinopathy and Partial Patellar Tendon Tears: A Novel Classification System. Am J Sports Med. 2020 Feb;48(2):359-369. doi: 10.1177/0363546519894333. Epub 202 — View Citation
Hernandez-Sanchez S, Hidalgo MD, Gomez A. Cross-cultural adaptation of VISA-P score for patellar tendinopathy in Spanish population. J Orthop Sports Phys Ther. 2011 Aug;41(8):581-91. doi: 10.2519/jospt.2011.3613. Epub 2011 Jul 12. — View Citation
Hutchison MK, Houck J, Cuddeford T, Dorociak R, Brumitt J. Prevalence of Patellar Tendinopathy and Patellar Tendon Abnormality in Male Collegiate Basketball Players: A Cross-Sectional Study. J Athl Train. 2019 Sep;54(9):953-958. doi: 10.4085/1062-6050-70- — View Citation
Jaffrin MY, Morel H. Body fluid volumes measurements by impedance: A review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys. 2008 Dec;30(10):1257-69. doi: 10.1016/j.medengphy.2008.06.009. Epub 2008 Aug 3. — View Citation
Kregel J, van Wilgen CP, Zwerver J. Pain assessment in patellar tendinopathy using pain pressure threshold algometry: an observational study. Pain Med. 2013 Nov;14(11):1769-75. doi: 10.1111/pme.12178. Epub 2013 Jun 26. — View Citation
Lopez-Royo MP, Gomez-Trullen EM, Ortiz-Lucas M, Galan-Diaz RM, Bataller-Cervero AV, Al-Boloushi Z, Hamam-Alcober Y, Herrero P. Comparative study of treatment interventions for patellar tendinopathy: a protocol for a randomised controlled trial. BMJ Open. — View Citation
Maffiuletti NA, Aagaard P, Blazevich AJ, Folland J, Tillin N, Duchateau J. Rate of force development: physiological and methodological considerations. Eur J Appl Physiol. 2016 Jun;116(6):1091-116. doi: 10.1007/s00421-016-3346-6. Epub 2016 Mar 3. — View Citation
Martin-Pintado-Zugasti A, Rodriguez-Fernandez AL, Fernandez-Carnero J. Postneedling soreness after deep dry needling of a latent myofascial trigger point in the upper trapezius muscle: Characteristics, sex differences and associated factors. J Back Muscul — View Citation
Moreno C, Mattiussi G, Nunez FJ, Messina G, Rejc E. Intratissue percutaneous electolysis combined with active physical therapy for the treatment of adductor longus enthesopathy-related groin pain: a randomized trial. J Sports Med Phys Fitness. 2017 Oct;57 — View Citation
Muhsen A, Moss P, Gibson W, Walker B, Jacques A, Schug S, Wright A. The Association Between Conditioned Pain Modulation and Manipulation-induced Analgesia in People With Lateral Epicondylalgia. Clin J Pain. 2019 May;35(5):435-442. doi: 10.1097/AJP.0000000 — View Citation
Rees JD, Maffulli N, Cook J. Management of tendinopathy. Am J Sports Med. 2009 Sep;37(9):1855-67. doi: 10.1177/0363546508324283. Epub 2009 Feb 2. — View Citation
Rio E, Moseley L, Purdam C, Samiric T, Kidgell D, Pearce AJ, Jaberzadeh S, Cook J. The pain of tendinopathy: physiological or pathophysiological? Sports Med. 2014 Jan;44(1):9-23. doi: 10.1007/s40279-013-0096-z. — View Citation
Rodriguez-Huguet M, Gongora-Rodriguez J, Lomas-Vega R, Martin-Valero R, Diaz-Fernandez A, Obrero-Gaitan E, Ibanez-Vera AJ, Rodriguez-Almagro D. Percutaneous Electrolysis in the Treatment of Lateral Epicondylalgia: A Single-Blind Randomized Controlled Tria — View Citation
Rodriguez-Huguet M, Gongora-Rodriguez J, Rodriguez-Huguet P, Ibanez-Vera AJ, Rodriguez-Almagro D, Martin-Valero R, Diaz-Fernandez A, Lomas-Vega R. Effectiveness of Percutaneous Electrolysis in Supraspinatus Tendinopathy: A Single-Blinded Randomized Contro — View Citation
Scott A, Squier K, Alfredson H, Bahr R, Cook JL, Coombes B, de Vos RJ, Fu SN, Grimaldi A, Lewis JS, Maffulli N, Magnusson SP, Malliaras P, Mc Auliffe S, Oei EHG, Purdam CR, Rees JD, Rio EK, Gravare Silbernagel K, Speed C, Weir A, Wolf JM, Akker-Scheek IVD — View Citation
Sdrulla AD, Xu Q, He SQ, Tiwari V, Yang F, Zhang C, Shu B, Shechter R, Raja SN, Wang Y, Dong X, Guan Y. Electrical stimulation of low-threshold afferent fibers induces a prolonged synaptic depression in lamina II dorsal horn neurons to high-threshold affe — View Citation
Segura León J.M., Medina i Mirapeix F., Valera Garrido F. Adverse effects of percutaneous needle electrolysis in carpal tunnel syndrome. Rev Fisioter Invasiva 2019;2:130
Shiose K, Tanabe Y, Ohnishi T, Takahashi H. Effect of regional muscle damage and inflammation following eccentric exercise on electrical resistance and the body composition assessment using bioimpedance spectroscopy. J Physiol Sci. 2019 Nov;69(6):895-901. — View Citation
Smidt N, van der Windt DA, Assendelft WJ, Mourits AJ, Deville WL, de Winter AF, Bouter LM. Interobserver reproducibility of the assessment of severity of complaints, grip strength, and pressure pain threshold in patients with lateral epicondylitis. Arch P — View Citation
Stoychev V, Finestone AS, Kalichman L. Dry Needling as a Treatment Modality for Tendinopathy: a Narrative Review. Curr Rev Musculoskelet Med. 2020 Feb;13(1):133-140. doi: 10.1007/s12178-020-09608-0. — View Citation
Valera Garrido F., Minaya Muñoz F., Ramírez Martínez P., Medina i Mirapeix F. Adverse effects associated to the application of ultrasound-guided percutaneous needle electrolysis. Rev Fisioter Invasiva 2019; 02(02): 115-116.
Valera-Garrido F, Minaya-Munoz F, Medina-Mirapeix F. Ultrasound-guided percutaneous needle electrolysis in chronic lateral epicondylitis: short-term and long-term results. Acupunct Med. 2014 Dec;32(6):446-54. doi: 10.1136/acupmed-2014-010619. Epub 2014 Au — View Citation
Valera-Garrido, Polidori F, Canet, Botet J, Ramírez F, Calvo P, et al. Clinical criteria for the application of percutaneous needle electrolysis in tendinopathies: An expert Consensus cocument and cross-sectional study among physical therapists. Revista Fisioterapia Invasiva / Journal of Invasive Techniques in Physical Therapy. 2019; 02. 055-061. 10.1055/s-0039-3402789.
Ylinen J. Pressure algometry. Aust J Physiother. 2007;53(3):207. doi: 10.1016/s0004-9514(07)70032-6. No abstract available. — View Citation
* Note: There are 43 references in all — Click here to view all references
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change in pain evoked with Von Frey Filaments. | We will use Von Frey Filaments to apply a 300g pressure in the evaluated areas (tibialis anterior muscle, inferior pole of the patella and patellar tendon). The subject will report the pain intensity verbally administered Numeric rate scale (NRS): 0 will be any pain and 10 will be the maximal perception of pain). The test will be performed with subject's eyes closed. | Pre-intervention and immediately after the intervention | |
| Secondary | Change in transcutaneous electrical detection threshold. | We will use a transcutaneous active electrode to evaluate electrical detection threshold on the medial region of the tibia. We will apply an alternating current with a frequency of 2 Hz, a pulse duration of 150 msec and the intensity will be increased progressively. When the subjects perceives the electrical current, the evaluator will record the current intensity as the electrical detection threshold. | Pre-intervention and immediately after the intervention | |
| Secondary | Change in percutaneous electrical detection threshold. | We will use the intervention needle as an active electrode to evaluate electrical detection threshold on the patellar tendon. The parameters of the electric current will be 2 Hz and 150 msec of pulse duration and the intensity will be increased progressively. When the subjects perceives the electrical current, the evaluator will record the current intensity as the electrical detection threshold. | Pre-intervention and immediately after the intervention | |
| Secondary | Change in pain evoked with a transcutaneous electrical stimulus. | We will use a transcutaneous active electrode to evaluate pain evoked with electrical stimulus on the medial side of the tibia. The parameters of electric current will be 2 hz and 150 msec of pulse duration and the intensity will be x3-4 respect to the electrical detection threshold determined using an electrical transcutaneous stimulus. The subject will report the pain intensity with a verbally administered numeric rate scale (NRS): 0 will be no pain and 10 will be the maximal perception of pain. | Pre-intervention and immediately after the intervention | |
| Secondary | Change in pain evoked with a percutaneous electrical stimulus. | We will use the intervention needle as an active electrode to evaluate electrical detection threshold on the patellar tendon. The parameters of electric current will be 2 Hz and 150 msec of pulse duration and the intensity will be x4-6 respect to the electrical detection threshold determined using an electrical percutaneous simulus. The subject will report the pain intensity with a verbally administered numeric rate scale (NRS): 0 will be no pain and 10 will be the maximal perception of pain. | Pre-intervention and immediately after the intervention | |
| Secondary | Change in maximum strength during knee extension with dynamometer | The subject will be sitting with 90 degrees knee flexion and the dynamometer located at the ankle. He/she will must extend the knee executing maximal isometric force during 5 seconds, 2 times with 1 minute to rest between them. | Pre-intervention and immediately after the intervention | |
| Secondary | Change in surface electromyography signal during knee extension | The subject will be sitting with 90 degrees knee flexion and the dynamometer located at the ankle and a surface electromyography located at the muscles vastus medialis and lateralis, from the muscle quadriceps femoris. He/she will must extend the knee executing maximal isometric force during 5 seconds, 2 times with 1 minute to rest between them. | Pre-intervention and immediately after the intervention | |
| Secondary | Questionnaire Victorian Institute of Sport Assessment - Patella (VISA-P) | The subject will fulfil the visa-p questionnaire, that assess symptoms, simple test of function, and the ability to play sports, to control that the sample recruited are healthy subjects. | One week before intervention | |
| Secondary | Change in patellar tendon bioimpedance | We will use four needles in the patellar tendon as electrodes to measure bioimpedance with a specific device (ImpediMed“s SFB7). We will measure using 256 frequences ranging from 3 Kilohertz (KHz) to 1 Megahertz (MHz) in different time frames. Firstly, we will measure three times prior to the introduction of the intervention needle. Then we will measure once more after the introduction of the intervention needle. Finally, we will performed four repeated measures after the intervention (immediately, 5, 10 and 15 minutes after of the intervention). | pre-intervention / baseline, immediately after the introduction the intervention needle and immediately after the intervention | |
| Secondary | Pain induced during bioimpedance measurement. | We will continuously measure pain intensity produced by the bioimpedance recording using a digital visual analogue scale (VAS) integrated in a potentiometer: 0 will be no pain and 10 will be the maximal perception of pain. | Immediately after the intervention, immediately after the introduction the intervention needle and immediately after of the intervention. | |
| Secondary | Conditioned pain modulation | First, we will measure pressure pain threshold with an algometer on the patellar tendon. Then, we will repeat the assesment of the pressure pain threshold on the patellar tendon meanwhile we apply a moderate painful pressure on the contralateral arm (5/10 on a numeric rate scale NRS: 0 will be no pain and 10 will be the maximal perception of pain) with a pressure cuff. The change between both pressure pain threshold will assess the conditioned pain modulation. After, we will repeat the same procedure but using cutaneous electrical threshold instead of pressure. | One week before the intervention | |
| Secondary | International Physical Activity Questionnaire (IPAQ) | The subjects will answer International Physical Activity Questionnaire to assess the level of physical activity. | One week before the intervention | |
| Secondary | Questionnaire about intervention effects past 24 hours. | The subjects will answer a questionnaire about the intervention effects and the possible side effects. | 24 hours after the intervention | |
| Secondary | Pain induced during intervention | We will continuously measure pain intensity produced by the intervention using a digital visual analogue scale (VAS) integrated in a potentiometer: 0 will be no pain and 10 will be the maximal perception of pain. | During the 16 minutes of intervention | |
| Secondary | Change in threshold to elicit mechanical perception with Von Frey Filaments | We will use Von Frey Filaments of increasing caliber to apply different pressure forces in the evaluated areas (tibialis anterior muscle, inferior pole of the patella and patellar tendon). The evaluator will score the caliber of the filament that produce a mechanical perception in the subject as the mechanical pressure threshold. The test will be performed with subject's eyes closed. | Pre-intervention and immediately after the intervention |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |